Germany grants BioNTech, CureVac $745 million to speed up coronavirus vaccine work
Topics: GERMANY BIONTECH CUREVAC
esearch Minister Anja Karliczek stressed that safety should remain the utmost priority to ensure vaccines will be accepted by the broader population.
“Even when the world is waiting for a vaccine we won’t take risky short cuts here,” she told a news conference in Berlin.
Karliczek said she does not expect a vaccine to be available for the broader population until the middle of 2021. ■